Sotera Health’s IPO

Cleary Gottlieb is representing Sotera Health Company and one of its principal shareholders, Warburg Pincus, in its $1.1 billion initial public offering of 46.6 million shares of common stock.

The offering priced on November 19, 2020, and closed on November 24, 2020. Sotera Health shares began trading on the Nasdaq Global Select Market on November 20, 2020 under the symbol “SHC.”

J.P. Morgan, Credit Suisse, Goldman Sachs, and Jefferies are acting as joint lead bookrunning managers and as representatives of the underwriters for the offering. In connection with the offering, the company granted the underwriters a 30-day overallotment option of up to an additional 6.99 million shares ($160.8 million.)

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion®, and Nelson Labs®. Sotera Health is committed to its mission: Safeguarding Global Health®.